Abstract:
A PROCESS FOR MAKING MINUTE CAPSULES IN WHICH MINUTE PARTICLES OF WATER-IMMISCIBLE MATERIAL, SUCH AS IRON OXIDE, AND HYDROPHILLIC, FILM-FORMING POLYMERIC MATERIAL, SUCH AS GELATIN, ARE DISPERSED IN WATER; COACERVATION IS INDUCED WHICH CAUSES THE POLYMERIC MATERIAL TO DEPOSIT ON EACH OF THE MINUTE PARTICLES AS A LIQUID WALL; AND A METALLIC CHELATING SALT, SUCH AS CHROMIC CHLORIDE OR COPPER SULFATE, IS ADDED TO HARDEN AND WATER-INSOLUBILIZE THE LIQUID DEPOSIT TO PRODUCE THE MINUTE, RIGID-WALLED CAPSULES.
Abstract:
PROCESS OF MICROENCAPSULATION EMPLOYING ALKALI-PRECURSOR (TYPE B) GELATIN AS THE ENCAPSULATING MACROCOLLOID, PARTICULARLY APPLICABLE TO THE FORMATION OF LIQUID CENTER MICROCAPSULES CONTAINING A BASIC (CATIONIC) NITROGEN COMPOUND. FOR EXAMPLE, AN AQUEOUS SOLUTION OF ALKALI-PRECURSOR GELATIN IS MIXED AT AN ALKALINE PH WITH A WATER-IMMISCIBLE ORGANIC SOLVENT SOLUTION OF A NITROGEN COMPOUND, SUCH AS AN AMINE OR A QUATERNARY. THE PH OF THE MIXTURE (VIZ, THE GELATIN PHASE) IS THEN REDUCED TO AT LEAST 4.5 AND PREFERABLY 3.8 OR BELOW, THE LIQUID PHASES BEING INTERMIXED TO DISPERSE AND EMULSIFY THE ORGANIC SOLVENT PHASE IN THE AQUEOUS PHASE, THEREBY PROVIDING MINUTE DROPLETS OF THE BASIC NITROGEN CONTAINING ORGANIC SOLVENT SURROUNDED BY THE AQUEOUS SOLUTION OF THE ALKALI-PRECURSOR GELATIN. AT THE LOW ACID PH, THE GELATIN FORMS A COATING ON THE DROPLETS AND PROVIDES ENCAPSULATING SKINS THEREFOR. WHILE THE ENCAPSULATED DROPLETS CAN BE RECOVERED AT THE LOW ACID PH, IT IS PREFERRED TO RAISE THE PH TO A PH ABOVE 5.5 (PREFERABLY 7.5-11), AND THEN RECOVER THE MICROCAPSULES. AN AUXILIARY COATING CAN BE APPLIED TO THE RECOVERED MICROCAPSULAR MATERIAL THUS PRODUCED BY CONTACTING THE MICROCAPSULES WITH AN AQUEOUS SOLUTION OF ACID-PRECURSOR GELATIN.
Abstract:
THE ANTI-INFLAMMATORY DRUG INDOMETHACIN IS MICROENCAPSULATED BY THE METHOD OF POLYMER/POLYMER INCOMPATIBILITY, COACERVATION USING EITHER AN ETHYLCELLULOSE-POLYETHYLENE SYSTEM OR A GELATIN-GUM ARABIC SYSTEM.
Abstract:
The present invention is directed to a method for producing advantageous microcapsules. Moreover, the present invention provides microcapsules obtained/obtainable by the method according to the invention.
Abstract:
The invention includes a novel microfluidic mixing chip configured for the production of lipid nano-particles (LNPs) and in particular LNPs encapsulating oligonucleotides, such as mRNA that may be used in various therapeutic applications such as vaccines and the like.